TRACON Pharmaceuticals, Inc. (TCON)

USD 0.03

(0.0%)

Operating Income Summary of TRACON Pharmaceuticals, Inc.

  • TRACON Pharmaceuticals, Inc.'s latest annual operating income in 2023 was -6.89 Million USD , up 75.27% from previous year.
  • TRACON Pharmaceuticals, Inc.'s latest quarterly operating income in 2024 Q2 was -2.91 Million USD , up 9.34% from previous quarter.
  • TRACON Pharmaceuticals, Inc. reported an annual operating income of -27.89 Million USD in 2022, up 1.6% from previous year.
  • TRACON Pharmaceuticals, Inc. reported an annual operating income of -28.34 Million USD in 2021, down -74.73% from previous year.
  • TRACON Pharmaceuticals, Inc. reported a quarterly operating income of -2.91 Million USD for 2024 Q2, up 9.34% from previous quarter.
  • TRACON Pharmaceuticals, Inc. reported a quarterly operating income of -7.31 Million USD for 2023 Q1, down -25.39% from previous quarter.

Annual Operating Income Chart of TRACON Pharmaceuticals, Inc. (2023 - 2012)

Historical Annual Operating Income of TRACON Pharmaceuticals, Inc. (2023 - 2012)

Year Operating Income Operating Income Growth
2023 -6.89 Million USD 75.27%
2022 -27.89 Million USD 1.6%
2021 -28.34 Million USD -74.73%
2020 -16.22 Million USD 27.24%
2019 -22.29 Million USD 35.82%
2018 -34.74 Million USD -90.77%
2017 -18.21 Million USD 29.9%
2016 -25.97 Million USD -10.69%
2015 -23.46 Million USD -279.79%
2014 -6.17 Million USD 18.27%
2013 -7.56 Million USD -44.66%
2012 -5.22 Million USD 0.0%

Peer Operating Income Comparison of TRACON Pharmaceuticals, Inc.

Name Operating Income Operating Income Difference
America Great Health -492.64 Thousand USD -1300.2%
Ampio Pharmaceuticals, Inc. -9.51 Million USD 27.527%
Aridis Pharmaceuticals, Inc. -29.99 Million USD 77.001%
Biora Therapeutics, Inc. -67.14 Million USD 89.726%
Bio-Path Holdings, Inc. -15.84 Million USD 56.46%
Better Therapeutics, Inc. -38.26 Million USD 81.972%
Calithera Biosciences, Inc. -42.07 Million USD 83.605%
Comera Life Sciences Holdings, Inc. -11.97 Million USD 42.373%
Gene Biotherapeutics, Inc. - USD Infinity%
eFFECTOR Therapeutics, Inc. -33.84 Million USD 79.618%
Eloxx Pharmaceuticals, Inc. -34.41 Million USD 79.959%
Evelo Biosciences, Inc. -108.46 Million USD 93.64%
Evolutionary Genomics, Inc. -2.01 Million USD -242.451%
Finch Therapeutics Group, Inc. -34 Million USD 79.713%
Galera Therapeutics, Inc. -46.95 Million USD 85.308%
Innovation1 Biotech Inc. -1.36 Million USD -404.466%
Kiromic BioPharma, Inc. -19.93 Million USD 65.405%
Molecular Templates, Inc. -10.46 Million USD 34.091%
Navidea Biopharmaceuticals, Inc. -14.05 Million USD 50.907%
NexImmune, Inc. -29.19 Million USD 76.371%
Orgenesis Inc. -53.63 Million USD 87.139%
Panbela Therapeutics, Inc. -51.29 Million USD 86.552%
Point of Care Nano-Technology, Inc. -78.01 Thousand USD -8741.663%
PaxMedica, Inc. Common Stock -16.14 Million USD 57.275%
Scopus BioPharma Inc. -11.71 Million USD 41.118%
Sorrento Therapeutics, Inc. -504.31 Million USD 98.632%
Statera Biopharma, Inc. -98.34 Million USD 92.986%
Trevena, Inc. -35.28 Million USD 80.452%
Vaxxinity, Inc. -58.28 Million USD 88.165%
Vaccinex, Inc. -22.88 Million USD 69.858%
Vicapsys Life Sciences, Inc. -1.04 Million USD -558.849%
Viracta Therapeutics, Inc. -50.69 Million USD 86.393%
ZIVO Bioscience, Inc. -7.26 Million USD 5.026%